Table 2. Subject Data.
| Age | Gender | Current AAP | Dose (mg/day) | CPZ eqs. | BMI | Suicide Hx |
| 53 | F | Quetiapine | 300 | 170.9 | 25 | No |
| 51 | F | Quetiapine | 12.5 | 7.1 | 25 | No |
| 57 | F | Quetiapine | 600 | 341.9 | 21 | No |
| 64 | M | NA | NA | 0.0 | 32 | No |
| 26 | F | Aripiprazole | 5 | 62.7 | 22 | No |
| 56 | F | Aripiprazole | 20 | 250.9 | 45 | No |
| 51 | F | Quetiapine | 400 | 227.9 | 33 | No |
| 45 | M | Quetiapine | 600 | 341.9 | 38 | No |
| 58 | F | Quetiapine | 100 | 57.0 | 33 | No |
| 61 | F | Risperidone | 4 | 332.1 | 29 | No |
| 22 | F | Aripiprazole | 7.5 | 94.1 | 22 | Yes |
| 47 | F | Clozapine | 200 | 144.1 | 26 | Yes |
| 33 | F | Paliperidone | 3 | 38 | Yes | |
| 54 | M | Aripiprazole | 15 | 188.2 | 33 | Yes |
| 50 | M | Aripiprazole | 25 | 313.6 | 24 | Yes |
| 25 | F | Risperidone | 2 | 166.0 | 21 | Yes |
| 25 | F | NA | NA | 0.0 | 39 | Yes |
| 42 | F | NA | NA | 0.0 | 20 | Yes |
| 60 | M | Quetiapine | 125 | 71.2 | 30 | Yes |
| 42 | M | Risperidone | 2 | 166.0 | 31 | Yes |
| 38 | M | Olanzapine | 7.5 | 140.7 | 30 | Yes |
| 37 | F | Quetiapine | 25 | 14.2 | 35 | Yes |
| 56 | F | Risperidone | 1 | 83.0 | 33 | Yes |
| 42 | F | Olanzapine | 15 | 281.5 | 35 | Yes |
| 56 | F | NA | NA | 0.0 | 29 | Yes |
| 54 | F | NA | NA | 0.0 | 43 | Yes |
| 35 | F | Ziprasidone | 160 | 255.5 | 23 | Yes |
Atypical antipsychotic (AAP) medications are given with actual dose and chlorpromazine equivalents (CPZ eqs.). Body mass index (BMI) and history of suicide attempt (Suicidal Hx), either Yes or No are also reported.